Pharmaceutical company Pfizer, US, has announced details of a membership agreement with open access publisher BioMed Central, UK, to cover publication costs for research articles published by its researchers.
Under this membership arrangement, Pfizer will centrally cover the publication fees for any researcher employed or funded by Pfizer when they submit a research article to one of BioMed Central's over 190 peer-reviewed open access journals. By funding open access publication fees in this way, Pfizer seeks to make it easy for its researchers to make their research results universally accessible.
More than 300 leading research institutions participate in BioMed Central's institutional membership scheme. A list of the latest Pfizer-funded research published in BioMed Central's open access journals can be viewed on Pfizer's member page on the BioMed Central website at http://www.biomedcentral.com/inst/48121/.
